Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now. Ann Intern Med. 2005 Feb 01; 142(3):212-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.